Skip to content

Clinical trials

Phase 1/2 Graft vs Host Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 1/2 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20023
20032
20042
20062
20072
20082
20094
20101
20112
20121
20132
20144
20151
20162
20173
20182
20192
20202
20211
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated8
Active, not recruiting7
Recruiting3
Not yet recruiting1
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center6
M.D. Anderson Cancer Center4
H. Lee Moffitt Cancer Center and Research Institute3
National Heart, Lung, and Blood Institute (NHLBI)3
National Cancer Institute (NCI)2
Northwell Health2
Pharmacyclics LLC.2
University of Michigan Rogel Cancer Center2
Ann & Robert H Lurie Children's Hospital of Chicago1
Bellicum Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease48
Leukemia11
Myelodysplastic Syndromes10
Leukemia, Myeloid, Acute7
Bronchiolitis Obliterans Syndrome6
Lymphoma6
Blast Crisis5
Hematologic Neoplasms5
Leukemia, Myeloid, Accelerated Phase5
Multiple Myeloma5

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.